MarketsandMarkets presents the Immunobio Series, an extraordinary trio of conferences taking place on 8-9 February 2024 at DoubleTree by Hilton, San Diego Mission Valley.
MarketsandMarkets 9th Annual Biomarker and Companion Diagnostics Conference: Dive into the world of biomarkers at our flagship event, uniting experts and industry leaders to drive innovation in healthcare, diagnostics, and personalized medicine. Explore groundbreaking research and applications, fostering collaboration and knowledge sharing.
MarketsandMarkets 6th Annual Next Gen Microbiome and Probiotics Conference: Discover the future of microbiome therapies and probiotics. Engage with professionals from diverse sectors to explore microbial innovation, regulatory pathways, and the vital microbiome probiotics connection. Delve into cutting-edge research and strategies for successful commercialization.
MarketsandMarkets Next Gen Immuno-Oncology Conference: Explore the forefront of cancer treatment at our inaugural Immuno-Oncology Conference. Join researchers and industry experts to discuss advancements in ADCs, Bispecific Antibodies, Cellular Therapy, and Immune Checkpoint Inhibitors. Participate in discussions, share insights, and shape the future of immuno-oncology.
Join us for this transformative event, where innovation meets collaboration, shaping the future of healthcare and biotechnology. MARKETSANDMARKETS IMMUNOBIO SERIES 2024- SAN DIEGO, CALIFORNIA
Vice President, Head, Translational Medicine, , Syncopation Lifesciences
Professor of Medicine, Chair GI Hospital Practice, Associate Program Director Internal Medicine Residency Program, Medical Director Desk and Secretarial Operations, Mayo Clinic
Chair of Microbiology & Immunology at MCW | Co-Founder, Rose Biosciences
Principal Scientist, Xbiome
Senior Medical & Scientific Advisory Board Member, BCD Bioscience
Vice President, Novome Biotechnologies
Director and Manager, Microbio Pharma
Instructor, Biology, Oregon State University
Director of Research and Development, FitBiomics
Founder & CEO, Larvol
Associate Professor of Computational Medicine and Bioinformatics, Department of Computational Medicine and Bioinformatics, University of Michigan Ann Arbor
Senior Vice President, Quantitative & Computational Biology , RAPT Therapeutics
Scientific Director, Immuno-Oncology, Precision Medicine, AbbVie
Director, Melanoma Program, UCSF Medical Center
CEO, Vaxiion Therapeutics
Chief Executive Officer, EzBiome Inc
Principal Scientist, NGS & Infrastructure Lead, Amgen
Medical Director, Cedars-Sinai
Senior Principal Scientist, Bristol Myers Squibb
Associate Professor, Johns Hopkins University
Professor, Innovation Lead Digital Health, Cleveland Clinic
Vice President, Molecular Diagnostics Global Medical Affairs, Ultragenyx
Executive Partner, Sofinnova Ventures
Chief Executive Officer, 4M Therapeutics Inc.
Assistant Professor, University of California, San Diego
Founder, CEO, Scaled Microbiomics
Sr. Manager, Clinical Biomarker, Repare Therapeutics
Vice President - Scientific Affairs, Danone
Principal Nutrition Scientist, Pharmavite
CEO and Founder, Symbiome
Chief Scientific Officer, M2B Pharma
Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science, Purdue Institute of Inflammation, Immunology and Infectious Disease
CEO, Primal Health Inc.
Associate Professor, Molecular Biology and Biochemistry School of Biological Sciences, University of California Irvine
Chief Executive Officer, A&G Pharmaceutical, Inc. | Precision Antibody
DoubleTree by Hilton, San Diego Mission Valley